Clinical Trial

Study of Viral Transduction of Human Auditory Sensory Cells for the Development of Gene Therapy

Study acronym: TREATGENE
Recruiting
View on ClinicalTrials.gov →
Summary
Gene therapy is a promising strategy to treat hearing loss and vestibular disorders, and Associated adenovirus (AAV) is shown as a good viral vector for inner ear therapy in animal models. This study aims to study in vitro viral transduction of AAV in human inner ear cells, collected during non-conservative surgeries for vestibular schwannoma.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-06-21; most recent amendment 2024-09-10.
Trial Details
NCT Number NCT03996824
Lead Sponsor Institut Pasteur
Collaborators: Assistance Publique - Hôpitaux de Paris
Conditions Hearing Loss, Sensorineural
Enrollment 100 participants
Start Date 2019-02-19
Primary Completion 2027-02-18 (estimated)
Study Completion 2027-02-18 (estimated)
Updated on ClinicalTrials.gov 2024-09-19